Why we built Carenostics
100,000 people are waiting for an organ transplant in the United States. Thirteen of them die every day, still waiting.
Carenostics co-founders Kanishka and Bharat Rao lost a family member to the gaps in the transplant system. He fell through the cracks at early diagnosis, at proactive treatment, and ultimately at transplant. The infrastructure that should have connected the dots across his care journey did not exist. By the time the system fully engaged, it was already too late.
Inspired to prevent other families from enduring what theirs did, they co-founded Carenostics on a conviction: that the gaps in transplant are not clinical failures but systems failures. And systems can be fixed.
What we believe
01
Healthcare was built for the crisis, not the journey.
American healthcare is exceptional at treating you when you are critically ill and in front of the right doctor. It was never designed to get you there. It bills for visits, not for coordination between them. By the time the system fully engages, it is often already too late.
02
Detection without action changes nothing.
Healthcare has gotten better at identifying patients who need care. What it has never built is the machinery to act on what it finds. Knowing someone is falling through the cracks is not the same as catching them. The job does not end at the flag. It ends at the outcome.
03
The clinicians are not the problem.
Better outcomes do not come from better clinicians. The clinicians are already excellent. They come from fixing the conditions under which excellent clinicians operate. Get the infrastructure right and the outcomes follow.
04
General tools do not work in specialized care.
Transplant teams have spent decades being handed software adapted from other service lines and designed for other workflows. Clinical teams only trust what was built specifically for their discipline. That is not resistance to technology. It is experience.
Built only for transplant.
Here to stay.
Built only for transplant
Carenostics is not a general AI company that happened to land in transplant. Coordinators, administrators, surgeons, and transplant-specific workflows are the reason the product exists.
End-to-end across the workflow
Referral, evaluation, listing, waitlist maintenance, and post-transplant monitoring. One assistant across the full patient journey.
Here to stay, and still building
The roadmap deepens within the discipline. New capabilities ship as centers need them. The partnership extends past implementation.
Leadership
Investors and Advisors
The chairman of Humana's board, the former CEO of Siemens Health Services, and the first-ever Chief Technology Officer of the United States have looked at what Carenostics is building and decided it is worth backing.
In the news
February 13, 2026
Carenostics named TMF 2026 AI/Emerging Tech Award winner
May 20, 2025
Carenostics named Finalist for Life Sciences Startup of the Year (PACT) for second year in a row
May 18, 2025
Alex Whitehead presents results of the Hackensack Meridian Health collaboration at ATS 2025